Early biomarkers may predict Alzheimer’s onset
New research published in the journal EMBO Molecular Medicine has revealed that circulating microRNAs, which are easily measured blood proteins, may identify the early risk of Alzheimer’s. Targeting these microscopic nucleotides for therapy could delay the onset of dementia by inhibiting cellular damage in the brain.
Related Posts
-
Pets may be linked to slower cognitive decline
Posted on Mar 24, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Hypertension in young adults affects brain later
Posted on Mar 8, 2022
-
Being lonely more often may raise dementia risk
Posted on Mar 3, 2022
Tags
Share This
